~~<i id='52CE352DBA'><strike id='52CE352DBA'><tt id='52CE352DBA'><pre id='52CE352DBA'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

hotspot

author：explore 2025-09-27 21:44:58 - browse：2

The Food and Drug Administration on Thursday approved a gene therapy to treat people with hemophilia A, an inherited and rare bleeding disorder.

The treatment, called Roctavian, is made by BioMarin Pharmaceutical. It was first approved in Europe in August 2022.

Roctavian is a one-time therapy that, in clinical trials, dramatically reduced bleeding episodes and helped patients live without the blood transfusions used to treat the disease. The FDA first rejected Roctavian in 2020, asking BioMarin to amass more data on its safety and long-term durability, and then delayed its decision again to account for additional evidence.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Inequities make cancer less preventable for women: report

knowledge

focus

hotspot

explore

Thedocumentary"ThreeIdenticalStrangers"chroniclestripletsborninthe1960swhowereseparatedasinfantsanda

WSS

These geoengineering technologies could help combat the climate crisis, scientists say

Duchenne patients, backed by ‘dark money’ group, to debate drug prices

Make 'food is medicine' a key part of White House nutrition meeting

Pfizer's Covid pill remains 89% effective in final analysis, company says

Did the public have the right to know Arthur Ashe had AIDS?

How the Dana

knowledge

hotspot

knowledge

Psychedelics group wrestles with new pharma identity

Listen: PBM conflicts, RSV vaccines, & the future of flu season

Medicare details structure of new drug price negotiation program

Ukraine, Russia accuse each other of planning to attack Europe's biggest nuclear plant

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

These geoengineering technologies could help combat the climate crisis, scientists say

Hollywood unions extend contract negotiations for actors

Kaiser Permanente unions announce official strike date

Moonlake's readout produced a cash windfall. Risks remain

Why is France rioting? What to know about the fatal police shooting of Nahel M

knowledge

Listen: Biogen's messy board & Laronde's data problem

Paxlovid should be available without a positive Covid test

Menendez indictment could see pharma lose a key ally

Pfizer's Covid pill remains 89% effective in final analysis, company says

Cigna to pay $172 million to settle Medicare Advantage fraud probe

Paxlovid should be available without a positive Covid test

knowledge

focus

hotspot

explore